Chromatin, Inc. and Syngenta Biotechnology, Inc. Collaborate to Develop Gene Stacking Technology for Soybean

Chromatin, Inc. announced today an extension of its research and commercial license agreement with Syngenta Biotechnology, Inc. for corn and soybeans for Chromatin’s proprietary gene stacking technology.

“Chromatin is pleased to expand its working relationship with Syngenta”
.The agreement furthers a three-year relationship between the two companies. Under a 2007 agreement, Syngenta obtAIned non-exclusive rights to use Chromatins gene stacking technology for trAIt genes in corn and soybeans, and in 2009, Syngenta obtAIned exclusive worldwide research and commercial license rights to that technology for use in sugar cane. Today, Chromatin announces that they have launched activities to further develop gene stacking technology for soybean applications.

Chromatin has developed a novel approach to gene stacking, using the plants own DNA to deliver several genes on a mini-chromosome. These mini-chromosomes are genetic elements that are built to deliver multiple trAIts and accelerate the development of new products, providing benefits to growers, industrial bioprocessors, and consumers.

"Chromatin is pleased to expand its working relationship with Syngenta,” sAId Daphne Preuss, Chromatin’s CEO. “As a leading agribusiness company with a global commitment to developing and improving crops, Syngenta is an ideal partner. With their continued commitment to extend efforts to test and develop gene stacking technologies in corn, soybean, sugar cane and other crops, this collaboration with Syngenta allows us to further implement our mini-chromosome technology into applications that will make a difference in meeting global food, feed and fuel challenges.”